Engerix-B (hepatitis B vaccine) availability
03 April 2017
GSK is currently experiencing an on-going supply constraint of Engerix-B® (Hepatitis B surface antigen recombinant (yeast) vaccine) adult in Australia due to a precautionary halt in the manufacturing process. Production is now back to normal however it will take time to re-build capacity.
At this stage we are unable to confirm a re-supply date.
Engerix-B paediatric dose is still available. GSK prioritises hepatitis B vaccine availability for those most at risk of infection and confirms uninterrupted supply of Engerix-B to all Australian State, Territory and Federal Government vaccination programs where Engerix-B is the vaccine of choice.
Twinrix® combined hepatitis A and B vaccine continues to be available.
We regret the inconvenience this supply constraint may cause patients and healthcare professionals as we work to re-establish supply.
For more information, please contact GSK medical information on 1800 033 109 or visit Engerix-B Consumer Medicine Information
Journalist enquiries, please contact Kim O’Donohue on 0477 322 431